TBG DIAGNOSTICS LIMITED - Announcements

Currently unlisted. Add to my watchlist

TBG Diagnostics Limited, formerly Progen Pharmaceuticals Limited, is a biotechnology... TBG Diagnostics Limited, formerly Progen Pharmaceuticals Limited, is a biotechnology company. The Company's principal activities include the discovery, research and development of pharmaceutical therapeutics for the treatment of human diseases, and the provision of contract services related to the process development, manufacture and quality assurance of biopharmaceutical products. The Company's segments include Research & Development, and Manufacturing. The Company is primarily engaged in the discovery and development of small molecule-based cancer therapeutics. The Company is focused on the development of the anti-angiogenesis and anti-metastatic oncology products pipeline. The Company's offerings include Muparfostat (PI-88) and PG545. Muparfostat (PI-88) is an anti-angiogenesis and anti-metastatic compound. Muparfostat (PI-88) is a dual angiogenesis and heparanase inhibitor. PG545 is an agent designed to target the tumor microenvironment.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

TDL	TBG to file Form 15-F to terminate SEC registration-TDL.AX		05/08/16	26.96KB	Share
TDL	TBG Diagnostics to replace exiting US auditor-TDL.AX		27/07/16	27.77KB	Share
TDL	Progen PG500 Series Pty Ltd Completes Phase I Trial-TDL.AX	PRICE SENSITIVE	22/07/16	31.47KB	Share
TDL	TBG Diagnostics commences HLA typing service in China-TDL.AX	PRICE SENSITIVE	19/07/16	38.67KB	Share
TDL	TBG to acquire controlling equity stake in RBC Biosciences-TDL.AX	PRICE SENSITIVE	29/06/16	335.38KB	Share
TDL	TBG Commences HLA Kit Sales with MD Anderson, Uni of Texas-TDL.AX	PRICE SENSITIVE	30/05/16	81.5KB	Share
TDL	TBG Receives Funding for HLA Typing Kit Development-TDL.AX	PRICE SENSITIVE	26/05/16	38.04KB	Share
TDL	Company Update - Board and Management Structure-TDL.AX		18/05/16	84.31KB	Share
TDL	Investor Presentation-TDL.AX		16/05/16	2.35MB	Share
TDL	Issue of Unlisted Options under Employee Share Option Plan-TDL.AX		13/05/16	168.42KB	Share
TDL	Change of Director's Interest Notice-TDL.AX		05/05/16	123.45KB	Share
TDL	Expiry of Unlisted Options - Mercer Capital		15/03/16	29.61KB	Share
TDL	Company Update - Sale of Pharmasynth Pty Ltd	PRICE SENSITIVE	04/03/16	34.48KB	Share
TDL	Half Year Report & Accounts	PRICE SENSITIVE	26/02/16	620.07KB	Share
TDL	Appointment of Edward Chang as Non-Executive Director		04/02/16	113.12KB	Share
TDL	Change in substantial holding		03/02/16	692.71KB	Share
TDL	Becoming a substantial holder		03/02/16	689.96KB	Share
TDL	Appendices - 3X and 3Z		02/02/16	140.25KB	Share
TDL	Consolidated Financial Statements for TBG Inc - Dec 2015		02/02/16	862.24KB	Share
TDL	Financial Statements for TBG Inc - Dec 2013 and 2014		02/02/16	672.46KB	Share
TDL	Securities Trading Policy		02/02/16	167.29KB	Share
TDL	Pre-Quotation Disclosure Notice with Various Confirmations		02/02/16	466.66KB	Share
TDL	Appendix 1A & Information Form and Checklist		02/02/16	576.18KB	Share
TDL	Reinstatement to Official Quotation - 3 February 2016	PRICE SENSITIVE	02/02/16	250.27KB	Share
TDL	ASX Notice - Reinstatement 3 February 2016		02/02/16	288.55KB	Share

TDL TBG to file Form 15-F to terminate SEC registration-TDL.AX
05/08/16		26.96KB	Share
TDL TBG Diagnostics to replace exiting US auditor-TDL.AX
27/07/16		27.77KB	Share
TDL Progen PG500 Series Pty Ltd Completes Phase I Trial-TDL.AX
22/07/16	PRICE SENSITIVE	31.47KB	Share
TDL TBG Diagnostics commences HLA typing service in China-TDL.AX
19/07/16	PRICE SENSITIVE	38.67KB	Share
TDL TBG to acquire controlling equity stake in RBC Biosciences-TDL.AX
29/06/16	PRICE SENSITIVE	335.38KB	Share
TDL TBG Commences HLA Kit Sales with MD Anderson, Uni of Texas-TDL.AX
30/05/16	PRICE SENSITIVE	81.5KB	Share
TDL TBG Receives Funding for HLA Typing Kit Development-TDL.AX
26/05/16	PRICE SENSITIVE	38.04KB	Share
TDL Company Update - Board and Management Structure-TDL.AX
18/05/16		84.31KB	Share
TDL Investor Presentation-TDL.AX
16/05/16		2.35MB	Share
TDL Issue of Unlisted Options under Employee Share Option Plan-TDL.AX
13/05/16		168.42KB	Share
TDL Change of Director's Interest Notice-TDL.AX
05/05/16		123.45KB	Share
TDL Expiry of Unlisted Options - Mercer Capital
15/03/16		29.61KB	Share
TDL Company Update - Sale of Pharmasynth Pty Ltd
04/03/16	PRICE SENSITIVE	34.48KB	Share
TDL Half Year Report & Accounts
26/02/16	PRICE SENSITIVE	620.07KB	Share
TDL Appointment of Edward Chang as Non-Executive Director
04/02/16		113.12KB	Share
TDL Change in substantial holding
03/02/16		692.71KB	Share
TDL Becoming a substantial holder
03/02/16		689.96KB	Share
TDL Appendices - 3X and 3Z
02/02/16		140.25KB	Share
TDL Consolidated Financial Statements for TBG Inc - Dec 2015
02/02/16		862.24KB	Share
TDL Financial Statements for TBG Inc - Dec 2013 and 2014
02/02/16		672.46KB	Share
TDL Securities Trading Policy
02/02/16		167.29KB	Share
TDL Pre-Quotation Disclosure Notice with Various Confirmations
02/02/16		466.66KB	Share
TDL Appendix 1A & Information Form and Checklist
02/02/16		576.18KB	Share
TDL Reinstatement to Official Quotation - 3 February 2016
02/02/16	PRICE SENSITIVE	250.27KB	Share
TDL ASX Notice - Reinstatement 3 February 2016
02/02/16		288.55KB	Share

REFRESH

First

TBG DIAGNOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available